An interventional study of Cessation counseling with adherence focus and Cessation counseling without adherence focus in Smoking, sponsored by RAND. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-04-06.
Sponsored by RAND · Not applicable, Interventional, and Treatment
The goal of this study is to evaluate a smoking cessation program for Latino HIV-positive smokers focused on improving adherence to using the nicotine skin patch.
325 studies on the registry are indexed under Smoking; 141 are open to participants now.
This study's enrollment of 40 is below the median of 117 across 250 interventional studies indexed under Smoking.
Browse Smoking studies →RAND is the lead sponsor of 114 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Brief smoking cessation counseling session (based on 5 A's approach) that includes a module focused on improving adherence to using the nicotine patch, plus 8-week supply of nicotine patches.
Behavioral: Cessation counseling with adherence focus
Brief smoking cessation counseling session (based on 5 A's approach) that does not include a module focused on improving nicotine patch adherence, plus 8-week supply of nicotine patches.
Behavioral: Cessation counseling without adherence focus
Continuous abstinence
No smoking from the target quit date through the 3-month follow-up
Time frame: 3 months post-quit date
biochemically-verified 7-day point prevalence abstinence
No smoking in the 7 prior days
Time frame: 3 months post-quit date
Nicotine patch adherence
Time frame: 3 months post-quit date
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.